Guardion Health Sciences Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Guardion Health Sciences regular Real Value cannot be determined due to lack of data. The prevalent price of Guardion Health Sciences is $0.0. Our model calculates the value of Guardion Health Sciences from evaluating the firm fundamentals such as return on equity of -0.5, and Return On Asset of -0.16 as well as inspecting its technical indicators and probability of bankruptcy.

Guardion Health Total Value Analysis

Guardion Health Sciences is currently projected to have valuation of (987.33 K) with market capitalization of 4.39 M, debt of 3.77 M, and cash on hands of 14.23 M. The negative valuation of Guardion Health may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Guardion Health fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(987.33 K)
4.39 M
3.77 M
14.23 M

Guardion Health Investor Information

About 21.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Guardion Health Sciences recorded a loss per share of 4.11. The entity last dividend was issued on the 24th of September 2024. The firm had 1:50 split on the 9th of January 2023. Guardion Health Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Guardion Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guardion Health has an asset utilization ratio of 102.77 percent. This signifies that the Company is making $1.03 for each dollar of assets. An increasing asset utilization means that Guardion Health Sciences is more efficient with each dollar of assets it utilizes for everyday operations.

Guardion Health Ownership Allocation

Roughly 77.61 (percent) of Guardion Health outstanding shares are held by general public with 1.3 % owned by insiders and only 21.09 pct. by outside corporations.

Guardion Health Profitability Analysis

The company reported the previous year's revenue of 12.25 M. Net Income was 158.03 K with profit before overhead, payroll, taxes, and interest of 4.52 M.

Guardion Health Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding1.3 M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Guardion Pink Sheet

If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities